Primary ovarian insufficiency - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Disease ReportsPrimary ovarian insufficiency

MeSH D016649 - primary ovarian insufficiency

Favorite

Competitive Landscape

Events Timeline

Commercial

Clinical Trials

Competitive landscape

D010049:Ovarian diseases

0 Companies

0 Drugs

Success rate

Primary ovarian insufficiency

$

Success rate

Events Timeline

Commercial

No Data

Clinical Trials

Historical Success Rate

Phase 1

67%

2/3

Phase 2

30%

3/10

Phase 3

75%

6/8

Approved: 4Overall Success rate: 15%

All Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Company name

Phase 1

Phase 2

Phase 3

Phase 4

Drug Name

Estradiol benzoate,

Estradiol valerate,

Ethinyl estradiol,

Levonorgestrel,

Estradiol benzoate,

Estradiol valerate

Glenmark Pharmaceuticals

Estradiol benzoate,

Estradiol valerate,

Estradiol benzoate,

Estradiol valerate,

Ethinyl estradiol,

Norelgestromin,

Johnson & Johnson

Estradiol benzoate,

Estradiol valerate,

Ethinyl estradiol,

Norelgestromin,

Ethinyl estradiol,

Estradiol benzoate,

Estradiol valerate,

Estradiol benzoate,

Estradiol valerate

Ethinyl estradiol

Estradiol benzoate,

Estradiol valerate,

Ethinyl estradiol,

Levonorgestrel,

Testosterone enanthate,

Testosterone undecanoate

Estradiol benzoate,

Estradiol valerate,

Ethinyl estradiol,

Levomefolate calcium,

Ethinyl estradiol,

Estradiol benzoate,

Estradiol valerate,

Estrogens conjugated

1

2

3

4

5

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use